How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

866 results for

Acne Vulgaris Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Acne Scarring in Skin of Color: Laser vs Microneedling

Acne Scarring in Skin of Color: Laser vs Microneedling Acne Scarring in Skin of Color: Laser vs Microneedling - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Acne Scarring in Skin of Color: Laser vs (...) efficacious in the treatment of acne scarring in patients with skin of color. Condition or disease Intervention/treatment Phase Acne Vulgaris Scar Device: Microneedling Device: Fractional non-ablative 1,540nm laser Not Applicable Detailed Description: This is a randomized, prospective clinical trial of 30 healthy patients with Fitzpatrick skin phototypes III-V with atrophic acne scars on the face who desire treatment of their scars. Subjects with skin phototypes III - V are being studied because

2018 Clinical Trials

182. Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring

Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) , medication, possible side effects and outcomes. A written informed consent was signed from each participant. Condition or disease Intervention/treatment Phase Acne Vulgaris Acne Scars Device: Dermaroller Drug: Topical Vitamin C Phase 1 Phase 2 Detailed Description: Study population: Each study group included 10 patients. Detailed history and full clinical examination was conducted for each patient. Patients had 6 visits at one month interval to receive treatment and evaluated one month after the end

2018 Clinical Trials

183. Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) patients.Furthermore, to investigate contrast effects, biodistribution and selective photothermolysis provided by gold microparticles and diode laser pulses, using RCM, OCT and histology. Condition or disease Intervention/treatment Phase Acne Vulgaris Device: SEB-250 Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 21 participants Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label

2018 Clinical Trials

184. Low Glycemic Index and Load Diet for the Treatment of Acne

Low Glycemic Index and Load Diet for the Treatment of Acne Low Glycemic Index and Load Diet for the Treatment of Acne - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Low Glycemic Index and Load Diet (...) /treatment Phase Acne Vulgaris Diet Modification Other: Normal diet Other: Low glycemic diet Drug: Adapalene 0.1% Gel Drug: Doxycycline Not Applicable Detailed Description: Clinical trial to determine the effect of adding a diet with low glycemic index and load to adults for the treatment of moderate acne. Adult patients with acne where recruited in two groups, A and B. Both groups of treatment were treated with doxycycline 100 mg per day plus adapalene 0.1% gel daily for 12 weeks. During pharmacologic

2018 Clinical Trials

185. The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne

The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers (...) Eligible for Study: 12 Years to 35 Years (Child, Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Diagnosis of acne vulgaris as determined by the study physician Mild-to-moderate acne defined as a grade 2 or 3 on the FDA Investigator Global Acne Assessment (IGA) for Acne vulgaris (Appendix 1)19 If female, Negative urine pregnancy test at the time of enrollment and negative urine pregnancy tests at follow up visits Agreement to comply with medically

2018 Clinical Trials

186. A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne

A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) First Posted : October 17, 2018 Last Update Posted : January 3, 2019 See Sponsor: Naked Biome, Inc. Collaborator: Therapeutics, Inc. Information provided by (Responsible Party): Naked Biome, Inc. Study Details Study Description Go to Brief Summary: Acne vulgaris is a disease caused my multiple factors including overgrowth of bacteria, clogged pores, excessive sebum production and hormonal changes. Recent literature from the Human Microbiome Project has shown there are bacterial strains specific

2018 Clinical Trials

187. The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin

The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) are hypothesizing that patients randomized to the treatment arm will have no statistically significant difference in total inflammatory lesion count or acne severity than the control arm. The investigators also hypothesize that adverse events will be equivalent in both groups and the treatment arm will report less cost associated with visits. Condition or disease Intervention/treatment Phase Acne Vulgaris Behavioral: Teledermatology visits Not Applicable Detailed Description: The role of telemedicine

2018 Clinical Trials

188. Current concepts in the management of acne vulgaris. (PubMed)

Current concepts in the management of acne vulgaris. 4237367 1969 04 18 2018 11 13 0008-4409 100 7 1969 Feb 15 Canadian Medical Association journal Can Med Assoc J Current concepts in the management of acne vulgaris. 340-3 Maddin S S eng Journal Article Review Canada Can Med Assoc J 0414110 0008-4409 F8VB5M810T Tetracycline AIM IM Acne Vulgaris chemically induced diagnosis drug therapy etiology genetics therapy Adolescent Adult Age Factors Diet Emotions Female Humans Male Marriage Pregnancy

Full Text available with Trip Pro

1969 Canadian Medical Association Journal

189. Rosacea - acne

rosacea). Phymatous changes (phymatous rosacea), most commonly rhinophyma. Ocular symptoms (ocular rosacea), such as red, gritty, dry or irritated eyes, and the person may describe a foreign body sensation in the eyes. Additional features such as burning, dry skin, oedema, and plaques may be present. Alternative conditions that present similarly to acne rosacea should be excluded (such as acne vulgaris, seborrhoeic dermatitis, and contact dermatitis). Management of acne rosacea is largely guided (...) by the type and severity of symptoms: Initial management includes lifestyle advice (such as avoidance of triggers), medication review (some drugs can aggravate acne rosacea), and management of any psychosocial problems. For mild or moderate papulopustular rosacea, treatment options include topical metronidazole or topical azelaic acid. For moderate to severe papulopustular rosacea, an oral tetracycline or erythromycin is recommended. Brimonidine 0.5% gel is an option if erythema (without prominent

2016 NICE Clinical Knowledge Summaries

190. The Clinical Impact and Cost-Effectiveness of Essential Oils and Aromatherapy for the Treatment of Acne Vulgaris: A Protocol for a Randomized Controlled Trial. (PubMed)

The Clinical Impact and Cost-Effectiveness of Essential Oils and Aromatherapy for the Treatment of Acne Vulgaris: A Protocol for a Randomized Controlled Trial. Acne is a prevalent, chronic, and sometimes severe skin disorder affecting an estimated 85% of adolescents and 50% of adults older than age 20 years. The psychosocial implications of acne can be considerable, often continuing long after physical symptoms resolve. Although effective acne medications are available, most exhibit adverse (...) -effect profiles that can leave the patient with few effective treatment options. Emerging evidence indicates that plant-derived essential oils may be a biologically plausible treatment for acne, although high-quality evidence of effectiveness and safety is lacking.To examine the clinical effectiveness and cost-effectiveness of essential oils and aromatherapy for the treatment of acne.This randomized, wait-list controlled trial will have three parallel groups; 192 participants with acne vulgaris, aged

Full Text available with Trip Pro

2013 Journal of Alternative and Complementary Medicine

191. Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety (...) and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01974323 Recruitment Status : Completed First Posted : November 1, 2013 Results First Posted : February 6, 2017 Last Update Posted : October 8, 2018 Sponsor: Almirall, S.A. Collaborator: Allergan

2013 Clinical Trials

192. A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Safety (...) and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01974141 Recruitment Status : Completed First Posted : November 1, 2013 Results First Posted : February 6, 2017 Last Update Posted : October 8, 2018 Sponsor: Almirall, S.A. Collaborator: Allergan

2013 Clinical Trials

193. BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. BLI1100 (...) -202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01815450 Recruitment Status : Completed First Posted : March 21, 2013 Last Update Posted : February 2, 2015 Sponsor: Braintree Laboratories Information provided by (Responsible Party

2013 Clinical Trials

194. An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01831960

2013 Clinical Trials

195. Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety (...) , Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01773122 Recruitment Status : Completed First Posted : January 23, 2013 Results First Posted : March 26, 2014 Last Update Posted : March 26, 2014 Sponsor: Allergan Information provided

2013 Clinical Trials

196. Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life

Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01835210 Recruitment Status : Completed First Posted : April 18, 2013 Last

2013 Clinical Trials

197. An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01785836 Recruitment Status : Withdrawn (Study was never

2013 Clinical Trials

198. Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01788384 Recruitment Status : Completed First Posted

2013 Clinical Trials

199. A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save (...) this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov

2013 Clinical Trials

200. Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01951417 Recruitment Status : Completed First Posted : September 26, 2013 Results First Posted

2013 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>